Ethyl pyruvate attenuates spinal cord ischemic injury with a wide therapeutic window through inhibiting high-mobility group box 1 release in rabbits

Anesthesiology

Volumn 110, Issue 6, 2009, Pages 1279-1286

  Wang, Qiang ^a   Ding, Qian ^a   Zhou, Yiming ^a   Gou, Xingchun ^b   Hou, Lichao ^a   Chen, Shaoyang ^a   Zhu, Zhenghua ^a   Xiong, Lize ^a  

^a FOURTH MILITARY MEDICAL UNIVERSITY   (China)

^b FOURTH MILITARY MEDICAL UNIVERSITY   (China)

Author keywords

[No Author keywords available]

Indexed keywords

ETHYLPYRUVATE; HIGH MOBILITY GROUP B1 PROTEIN; PYRUVIC ACID DERIVATIVE; UNCLASSIFIED DRUG; COLORING AGENT; HBP1 PROTEIN, HUMAN; HIGH MOBILITY GROUP PROTEIN; PYRUVIC ACID ETHYL ESTER; REPRESSOR PROTEIN;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ANTIINFLAMMATORY ACTIVITY; ARTICLE; CONCENTRATION RESPONSE; CONTROLLED STUDY; DOSE TIME EFFECT RELATION; DRUG MECHANISM; ENZYME LINKED IMMUNOSORBENT ASSAY; HISTOPATHOLOGY; MALE; MOTONEURON; NEUROPROTECTION; NICK END LABELING; NONHUMAN; PRIORITY JOURNAL; RABBIT; SCORING SYSTEM; SPINAL CORD ISCHEMIA; ANIMAL; APOPTOSIS; BLOOD GAS ANALYSIS; BODY TEMPERATURE; DRUG ANTAGONISM; DRUG EFFECT; GLUCOSE BLOOD LEVEL; HEMODYNAMICS; HINDLIMB; METABOLISM; PATHOLOGY; PATHOPHYSIOLOGY; PHYSIOLOGY; REPERFUSION INJURY;

ANIMALS; APOPTOSIS; BLOOD GAS ANALYSIS; BLOOD GLUCOSE; BODY TEMPERATURE; COLORING AGENTS; ENZYME-LINKED IMMUNOSORBENT ASSAY; HEMODYNAMICS; HIGH MOBILITY GROUP PROTEINS; HINDLIMB; IN SITU NICK-END LABELING; MALE; PYRUVATES; RABBITS; REPERFUSION INJURY; REPRESSOR PROTEINS; SPINAL CORD ISCHEMIA;

EID: 67049132380     PISSN: 00033022     EISSN: 15281175     Source Type: Journal    
DOI: 10.1097/ALN.0b013e3181a160d6     Document Type: Article

References (30)

1. Zvara DA: Thoracoabdominal aneurysm surgery and the risk of paraplegia: contemporary practice and future directions. J Extra Corpor Technol 2002; 34:11-7
2. Keane RW, Davis AR, Dietrich WD: Inflammatory and apoptotic signaling after spinal cord injury. J Neurotrauma 2006; 23:335-44
3. Beattie MS, Farooqui AA, Bresnahan JC: Review of current evidence for apoptosis after spinal cord injury. J Neurotrauma 2000; 17:915-25
4. Beattie MS: Inflammation and apoptosis: Linked therapeutic targets in spinal cord injury. Trends Mol Med 2004; 10:580-3
5. Ulloa L, Ochani M, Yang H, Tanovic M, Halperin D, Yang R, Czura CJ, Fink MP, Tracey KJ: Ethyl pyruvate prevents lethality in mice with established lethal sepsis and systemic inflammation. Proc Natl Acad SciUSA 2002; 99:12351-6
6. Woo YJ, Taylor MD, Cohen JE, Jayasankar V, Bish LT, Burdick J, Pirolli TJ, Berry MF, Hsu V, Grand T: Ethyl pyruvate preserves cardiac function and attenuates oxidative injury after prolonged myocardial ischemia. J Thorac Cardiovasc Surg 2004; 127:1262-9
7. Taylor MD, Grand TJ, Cohen JE, Hsu V, Liao GP, Zentko S, Berry MF, Gardner TJ, Woo YJ: Ethyl pyruvate enhances ATP levels, reduces oxidative stress and preserves cardiac function in a rat model of off-pump coronary bypass. Heart Lung Circ 2005; 14:25-31
8. Kim JB, Yu YM, Kim SW, Lee JK: Anti-inflammatory mechanism is involved in ethyl pyruvate-mediated efficacious neuroprotection in the postischemic brain. Brain Res 2005; 1060:188-92
9. Yu YM, Kim JB, Lee KW, Kim SY, Han PL, Lee JK: Inhibition of the cerebral ischemic injury by ethyl pyruvate with a wide therapeutic window. Stroke 2005; 36:2238-43
10. Kim JB, Sig Choi J, Yu YM, Nam K, Piao CS, Kim SW, Lee MH, Han PL, Park JS, Lee JK: HMGB1, a novel cytokine-like mediator linking acute neuronal death and delayed neuroinflammation in the postischemic brain. J Neurosci 2006; 26:6413-21
11. Faraco G, Fossati S, Bianchi ME, Patrone M, Pedrazzi M, Sparatore B, Moroni F, Chiarugi A: High mobility group box 1 protein is released by neural cells upon different stresses and worsens ischemic neurodegeneration in vitro and in vivo. J Neurochem 2007; 103:590-603
12. Kim JB, Lim CM, Yu YM, Lee JK: Induction and subcellular localization of high-mobility group box-1 (HMGB1) in the postischemic rat brain. J Neurosci Res 2008; 86:1125-31
13. Yamada S, Maruyama I: HMGB1, a novel inflammatory cytokine. Clin Chim Acta 2007; 375:36-42
14. Ulloa L, Fink MP, Tracey KJ: Ethyl pyruvate protects against lethal systemic inflammation by preventing HMGB1 release. Ann NY Acad Sci 2003; 987:319-21
15. Dong H, Xiong L, Zhu Z, Chen S, Hou L, Sakabe T: Preconditioning with hyperbaric oxygen and hyperoxia induces tolerance against spinal cord ischemia in rabbits. ANESTHESIOIOGY2002; 96:907-12
16. Nie H, Xiong L, Lao N, Chen S, Xu N, Zhu Z: Hyperbaric oxygen preconditioning induces tolerance against spinal cord ischemia by upregulation of antioxidant enzymes in rabbits. J Cereb Blood Flow Metab 2006; 26:666-74
17. Wang Q, Gou X, Xiong L, Jin W, Chen S, Hou L, Xu L: Trans-activator of transcription-mediated delivery of NEP1-40 protein into brain has a neuroprotec- tive effect against focal cerebral ischemic injury via inhibition of neuronal apoptosis. ANESTHESIOIOGY2008; 108:1071-80
18. Yamada S, Inoue K, Yakabe K, Imaizumi H, Maruyama I: High mobility group protein 1 (HMGB1) quantified by ELISA with a monoclonal antibody that does not cross-react with HMGB2. Clin Chem 2003; 49:1535-7
19. Fiane AE, Videm V, Lingaas PS, Heggelund L, Nielsen EW, Geiran OR, Fung M, Mollnes TE: Mechanism of complement activation and its role in the inflammatory response after thoracoabdominal aortic aneurysm repair. Circulation 2003; 108:849-56
20. Sayer FT, Kronvall E, Nilsson OG: Methylprednisolone treatment in acute spinal cord injury: The myth challenged through a structured analysis of published literature. Spine J 2006; 6:335-43
21. Lim SC, Choi JE, Kim CH, Duong HQ, Jeong GA, Kang HS, Han SI: Ethyl pyruvate induces necrosis-to-apoptosis switch and inhibits high mobility group box protein 1 release in A549 lung adenocarcinoma cells. Int J Mol Med 2007;20:187-92
22. Fink MP: Ethyl pyruvate: A novel anti-inflammatory agent. J Intern Med 2007; 261:349-62
23. Tsung A, Sahai R, Tanaka H, Nakao A, Fink MP, Lotze MT, Yang H, Li J, Tracey KJ, Geller DA, Billiar TR: The nuclear factor HMGB1 mediates hepatic injury after murine liver ischemia-reperfusion. J Exp Med 2005;201:1135-43
24. Watanabe T, Kubota S, Nagaya M, Ozaki S, Nagafuchi H, Akashi K, Taira Y, Tsukikawa S, Oowada S, Nakano S: The role of HMGB-1 on the development of necrosis during hepatic ischemia and hepatic ischemia/reperfusion injury in mice. J Surg Res 2005; 124:59-66
25. Wang H, Li W, Goldstein R, Tracey KJ, Sama AE: HMGB1 as a potential therapeutic target. Novartis Found Symp 2007; 280:73-85
26. Liu K, Mori S, Takahashi HK, Tomono Y, Wake H, Kanke T, Sato Y, Hiraga N, Adachi N, Yoshino T, Nishibori M: Anti-high mobility group box 1 monoclonal antibody ameliorates brain infarction induced by transient ischemia in rats. FASEBJ 2007;21:3904-16
27. Goldstein RS, Gallowitsch-Puerta M, Yang L, Rosas-Ballina M, Huston JM, Czura CJ, Lee DC, Ward MF, Bruchfeld AN, Wang H, Lesser ML, Church AL, Litroff AH, Sama AE, Tracey KJ: Elevated high-mobility group box 1 levels in patients with cerebral and myocardial ischemia. Shock 2006; 25:571-4
28. Hayashi T, Sakurai M, Abe K, Sadahiro M, Tabayashi K, Itoyama Y: Apo- ptosis of motor neurons with induction of caspases in the spinal cord after ischemia. Stroke 1998;29:1007-12
29. Jiang W, Bell CW, Pisetsky DS: The relationship between apoptosis and high-mobility group protein 1 release from murine macrophages stimulated with lipopolysaccharide or polyinosinic-polycytidylic acid. J Immunol 2007; 178:6495-503
30. Qin S, Wang H, Yuan R, Li H, Ochani M, Ochani K, Rosas-Ballina M, Czura CJ, Huston JM, Miller E, Lin X, Sherry B, Kumar A, Larosa G, Newman W, Tracey KJ, Yang H: Role of HMGB1 in apoptosis-mediated sepsis lethality. J Exp Med 2006;203:1637-42